Lead Product(s): GDD3898
Therapeutic Area: Nutrition and Weight Loss
Highest Development Status: Phase II Product Type: Undisclosed
Partner/Sponsor/Collaborator: Maxim Merchant Capital
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Series A Financing March 03, 2020
The financing will support the development of its lead therapeutic candidate GDD3898.